Company Overview of Feldan Bio Inc.
Feldan Bio Inc., a recombinant protein company, discovers, develops, manufactures, and markets recombinant proteins and molecular biology reagents for life science companies and research laboratories in the United States, Canada, Europe, and internationally. The company develops Feldan Shuttle, a protein-based technology platform that delivers transcription factors and genome editing tools in clinical applications. It also provides Anti-AFP, a mouse monoclonal antibody; B-Cell culture supplement; FastFect, a transfection reagent; Hybridoma cloning booster; Hybridoma fusion and cloning booster; Hybridoma fusion booster; recombinant fibroblast growth factor-2; recombinant human epidermal growt...
4975 Rideau Street
Quebec, QC G2E 5H5
Founded in 1999
Key Executives for Feldan Bio Inc.
Co-Founder, Chief Executive Officer and Director
Compensation as of Fiscal Year 2016.
Feldan Bio Inc. Key Developments
Feldan Therapeutics and Elasmogen Announce Research Agreement with Amgen to Develop Intracellular Biologics
May 9 17
Elasmogen Ltd. and Feldan Therapeutics announce a research collaboration with Amgen, to develop and deliver novel intracellular biologics. The collaboration combines the unique capabilities of Feldan's Shuttle platform and Elasmogen's soloMER™ technology to develop the delivery system and binding domains to two undisclosed intracellular targets for Amgen. The Feldan Shuttle technology is a novel peptide-based delivery method that enables the highly efficient introduction of foreign proteins into cells. Elasmogen's soloMER's are the smallest naturally occurring binding domains. Their small size and robust nature, particularly the resistance to changes in pH and ability to bind in intracellular conditions makes them the perfect complement to Feldan's technology.
Feldan Therapeutics Presents at 9th Annual Conference Biotech Showcase, Jan-09-2017
Dec 20 16
Feldan Therapeutics Presents at 9th Annual Conference Biotech Showcase, Jan-09-2017 . Venue: HILTON SAN FRANCISCO UNION SQUARE, 333 O'Farrell Street, San Francisco, CA 94102, United States.
Feldan Bio Inc. Presents at Redefining Early Stage Investments (RESI) Conference 2016, Jan-12-2016
Jan 7 16
Feldan Bio Inc. Presents at Redefining Early Stage Investments (RESI) Conference 2016, Jan-12-2016 . Venue: Marine's Memorial Club & Hotel, 609 Sutter St, San Francisco, CA 94102, United States.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|